Abstract
To present a multi-institutional experience evaluating the use of systemic therapy in patients undergoing cytoreductive nephrectomy (CN), as prospective randomized trials showed a survival benefit for CN in patients with metastatic renal cell carcinoma treated with immunotherapy, and these data have been extrapolated to support CN in the era of targeted therapy, but the likelihood that patients with metastatic kidney cancer who undergo CN will receive systemic treatment afterward remains poorly defined. In all, 141 patients who underwent CN between 1990 and 2008 were identified from our Institutional Kidney Cancer Registries. Kaplan-Meier analyses and Cox regression models were used to assess the effect of clinicopathological and perioperative variables on patients' subsequent receipt of systemic therapy, and survival after CN. Overall, 98 of the 141 patients (69.5%) received postoperative systemic treatment, at a median (range) of 2.5 (0.1-61.5) months after CN. In this group, 52 (53%) patients received immunotherapy, 34 (35%) targeted agents, and 12 (12%) other regimens. By contrast, 43 patients (31%) did not receive systemic therapy, because of rapid disease progression (13, 30%), decision for surveillance by medical oncolog...Continue Reading
References
Mar 1, 1977·The Journal of Urology·J E MontieD K Montague
Jul 1, 1995·The Journal of Urology·R T BennettJ Fleischmann
Oct 23, 1997·The Journal of Urology·M M WaltherS A Rosenberg
Jun 17, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J P KavoliusM S Brady
Nov 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R J MotzerJ Ferrara
Oct 5, 2001·Lancet·G H MickischUNKNOWN European Organisation for Research and Treatment of Cancer (EORTC) Genitourinary Group
Jan 5, 2002·The New England Journal of Medicine·R C FlaniganE D Crawford
Mar 2, 2002·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·S RetsasK MacRae
Dec 12, 2003·Cancer·Bradley C LeibovichArie Belldegrun
Feb 10, 2004·The Journal of Urology·Robert C FlaniganE David Crawford
Sep 19, 2006·Urology·Surena F MatinChristopher G Wood
Jan 12, 2007·The New England Journal of Medicine·Robert J MotzerRobert A Figlin
Jan 12, 2007·The New England Journal of Medicine·Bernard EscudierUNKNOWN TARGET Study Group
May 8, 2007·Urology·Wassim KassoufChristopher G Wood
May 12, 2007·European Urology·Paul C M S Verhagen
May 19, 2007·The Journal of Urology·Brian I Rini, Steven C Campbell
Jun 1, 2007·The New England Journal of Medicine·Gary HudesUNKNOWN Global ARCC Trial
Jan 22, 2008·European Urology·Vitaly Margulis, Christopher G Wood
Feb 22, 2008·CA: a Cancer Journal for Clinicians·Ahmedin JemalMichael J Thun
Apr 16, 2008·BJU International·Brian ShuchArie S Belldegrun
May 20, 2008·The Journal of Urology·Vitaly MargulisChristopher G Wood
Jul 29, 2008·Cancer·Brian ShuchAllan J Pantuck
Aug 2, 2008·Current Opinion in Urology·Vitaly MargulisChristopher G Wood
Oct 1, 2008·Cancer·Arie S BelldegrunAllan J Pantuck
Dec 2, 2008·Urology·Laurent ZiniPierre I Karakiewicz
Dec 23, 2008·The Journal of Urology·Primo N LaraUNKNOWN Southwest Oncology Group Trial S8949
Dec 23, 2008·The Journal of Urology·Anil A ThomasSteven C Campbell
Apr 18, 2009·The Journal of Urology·K Robin YabroffAlison Martin
Jun 23, 2009·The Journal of Urology·Astrid A M van der VeldtAxel Bex
Citations
Jun 17, 2011·Der Urologe. Ausg. A·C Wiesner, A Haferkamp
Apr 7, 2010·World Journal of Urology·Paul Russo
Aug 4, 2010·Targeted Oncology·Eric A SingerRamaprasad Srinivasan
Nov 23, 2011·Current Urology Reports·Paul L Crispen, Michael L Blute
Apr 13, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·T PowlesA Bex
Mar 20, 2014·PloS One·Yong WeiWen-Hui Qian
Jan 12, 2012·The Oncologist·Brian ShuchRamaprasad Srinivasan
Nov 27, 2015·Future Oncology·Camillo PortaThomas E Hutson
Jul 23, 2011·Urology·Rebecca L O'MalleyThomas Schwaab
Jan 28, 2017·International Braz J Urol : Official Journal of the Brazilian Society of Urology·Brandon J ManleySeth A Strope
Oct 2, 2015·Therapeutic Advances in Urology·Stephen H Culp
Jul 23, 2016·European Urology·Axel BexUNKNOWN European Association of Urology
Aug 3, 2018·World Journal of Urology·Lorenzo MarconiAxel Bex
Mar 27, 2018·The Journal of Urology·Bimal BhindiStephen A Boorjian
Dec 3, 2014·The Journal of Urology·Marc C SmaldoneStephen A Boorjian
Sep 25, 2016·The Journal of Urology·Boris GershmanBradley C Leibovich
Jun 29, 2011·Expert Review of Anticancer Therapy·Lance C PagliaroEric Jonasch
Jul 16, 2019·Current Opinion in Urology·Jeffrey GrahamDaniel Y C Heng
Jun 10, 2020·Cancer·Andrew G McIntoshChristopher G Wood
Feb 27, 2013·World Journal of Urology·Axel Bex, John Haanen
Nov 26, 2011·Expert Review of Anticancer Therapy·Srinivas VourgantiGennady Bratslavsky
Jun 22, 2012·Expert Review of Anticancer Therapy·Axel Bex, Tom Powles
Aug 11, 2020·BioMed Research International·Xiaoli MengRuwu Yang
Aug 16, 2014·BJU International·Anthony T CorcoranAlexander Kutikov
Oct 15, 2020·Nature Reviews. Urology·Kyle A BlumA Ari Hakimi
Jan 2, 2021·European Urology Oncology·Michele MarchioniUNKNOWN EAU-Young Academic Urologist Kidney Cancer Group
Feb 13, 2021·Cancers·Stepan M EsagianPavlos Msaouel
Jul 22, 2021·Cancer·Andrew W SilagyA Ari Hakimi
Oct 17, 2021·Current Urology Reports·Roser Vives DilmeJesús Moreno Sierra